Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: A prospective surveillance study

Clinical Infectious Diseases

Volumn 42, Issue 2, 2006, Pages 195-203

  McNeil, Shelly A ^a,d   Malani, Preeti N ^a,c   Chenoweth, Carol E ^a   Fontana, Robert J ^b   Magee, John C ^a   Punch, Jeffrey D ^a   Mackin, Monica L ^a   Kauffman, Carol A ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTETAN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; NEOMYCIN; PIPERACILLIN PLUS TAZOBACTAM; PROTON PUMP INHIBITOR; QUINOLONE; SULTAMICILLIN;

ADULT; AGED; ANAMNESIS; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DEMOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTEROCOCCAL INFECTION; FECES ANALYSIS; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RATE; INTENSIVE CARE UNIT; LABORATORY TEST; LENGTH OF STAY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NONHUMAN; PARACENTESIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; ANTI-BACTERIAL AGENTS; CARRIER STATE; CASE-CONTROL STUDIES; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 30144438575     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/498903     Document Type: Article

References (38)

1. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2003. Am J Infect Control 2003; 31:481-98.
2. Edmond M, Ober J, Weinbaum D, et al, Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20:1126-33.
3. Wells C, Juni B, Cameron S, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995; 21:45-50.
4. Linden P, Pasculle A, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-sensitive E. faecium. Clin Infect Dis 1996; 22:663-70.
5. Papanicolau G, Meyers B, Meyers J, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996; 23:760-6.
6. Bach PB, Malak SF, Jurcic J, et al. Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia. Infect Control Hosp Epidemiol 2002; 23:471-4.
7. Roghmann MC, Qaiyumi S, Johnson JA, Schwalbe R, Morris JG Jr. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years. Clin Infect Dis 1997; 24:514-5.
8. Lautenbach, E, Bilker WB, Brennan, PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 1999; 20:318-23.
9. Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996; 156:1458-62.
10. Kuehnert MJ, Jernigan JA, Rimland D, Jarvis WR. Association between mucositis severity and vancomycin-resistant entrerococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp Epidemiol 1999; 20:660-3.
11. DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005; 191:588-95.
12. Orloff SL, Busch AMH, Olyaei AJ, et al. Vancomycin-resistant Enterococcus in liver transplant patients. Am J Surg 1999; 177:418-22.
13. Newell KA, Millis JM, Arnow PM, et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998; 65:439-42.
14. Patel R, Allen SL, Manahan JM, et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl 2001; 7:27-31.
15. Dominguez EA, Davis JC, Langnas AN, Winfield B, Cavalieri SJ, Rupp ME. An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients. Liver Transpl Surg 1997; 3:586-90.
16. Bakir M, Bova JL, Newell KA, Millis JM, Buell JF, Arnow PM. Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients. Transplantation 2001; 72:1032-7.
17. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. Centers for Disease Control definitions for nosocomial infections. Am J Infect Control 1988; 16:128-40.
18. Willey BM, Jones RN, McGeer A, et al. Practical approach to the identification of clinically relevant Enterococcus species, Diagn Microbiol Infect Dis 1999; 34:165-71.
19. Donabedian S, Chow JW, Shlaes DM, Green M, Zervos MJ. DNA probes and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level. J Clin Microbiol 1995; 33:2233-9.
20. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
21. Ostrowsky BE, Venkataraman L, d'Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med 1999; 159:1467-72.
22. d'Agata EM, Green WK, Schulman G, Li H, Tang YW, Schaffner W. Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition. Clin Infect Dis 2001; 32:23-9.
23. Donskey CJ, Chowdry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000; 343:1925-32.
24. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 2000; 181:1830-3.
25. Montecalvo MA, Lencastre H, Carraher M, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995; 16:680-5.
26. Baden LR, Thiemke W, Skolnik A, et al. Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance." Clin Infect Dis 2001; 33:1654-60.
27. Roghmann MC, Aqiyumi S, Schwalbe R, Morris JG Jr. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1997; 18:679-80.
28. Donskey CJ, Hoyen CK, Das SM, Helfand MS, Hecker MT. Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol 2002; 23:436-40.
29. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 2002; 162:2223-8.
30. Bach PB, Malak SF, Jurcic J, et al. Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia. Infect Control Hosp Epidemiol 2002; 23:471-4.
31. Vergis EN, Hayden MK, Chow JW, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann Intern Med 2001; 135:484-92.
32. Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus in a level 1 trauma center. Clin Infect Dis 2002; 34:922-9.
33. Price CS, Paule S, Noskin GA, Peterson LR. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003; 37:921-8.
34. Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis 2003; 37:326-32.
35. Hachem R, Graviss L, Hanna H, et al. Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol 2004; 25:391-4.
36. Hererro IA, Issa NC, Patel R. Nosocomial spread of linezolid-resistant vancomycin-resistant Enterococcus faecium. N Engl J Med 2002; 346:867-8.
37. Issa NC, Patel R. New issues in bacterial infections in solid organ transplant recipients. Infect Med 2004; 21:234-44.
38. Avery RK. Recipient screening prior to solid-organ transplantation. Clin Infect Dis 2002; 35:1513-9.